Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Dec 05, 24
1 min read


iDose® TR represents a revolutionary advancement in the treatment of glaucoma, providing a long-term and efficient method for managing intraocular pressure (IOP). Differing from traditional eye drops that require daily administration, iDose® TR is a compact, implantable device designed to deliver a controlled medication delivery directly into the eye over an prolonged period. This cutting-edge approach removes the hassle of daily applications, significantly improving patient adherence and overall treatment effectiveness.

At Eye Center South, we are excited to provide iDose® TR as part of our all-encompassing glaucoma care. The device is inserted during a minimally invasive procedure, ensuring patient comfort and convenience. Once in place, it ensures a steady release of glaucoma medication, keeping IOP levels consistent and protect your vision. Patients who find challenges in the challenges of daily eye drop regimens can benefit greatly from this next-generation treatment.



Visit for more info At Eye Center South